Emergent BioSolutions Inc. (EBS)
NYSE·Healthcare·Biotechnology
$7.57
+2.09%
Mkt Cap $372.52M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+58.6%
Consensus $12.00 vs current $7.57
NYSE·Healthcare·Biotechnology
$7.57
+2.09%
Mkt Cap $372.52M
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$12.00
Range $12.00 – $12.00
+58.6%
Consensus $12.00 vs current $7.57